Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 7329195, 10 pages
https://doi.org/10.1155/2018/7329195
Research Article

Dynamic Changes in Plasma MicroRNAs Have Potential Predictive Values in Monitoring Recurrence and Metastasis of Nasopharyngeal Carcinoma

1Department of Otolaryngology-Head and Neck Surgery, Guangzhou General Hospital of People’s Liberation Army of China, Guangzhou, Guangdong 510010, China
2Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China

Correspondence should be addressed to Xiangping Li; moc.qq@261123il

Received 24 July 2017; Revised 3 October 2017; Accepted 15 October 2017; Published 18 January 2018

Academic Editor: Leon Spicer

Copyright © 2018 Xia Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. L. K. Chua, J. T. S. Wee, E. P. Hui, and A. T. C. Chan, “Nasopharyngeal carcinoma,” The Lancet, vol. 387, no. 10022, pp. 1012–1024, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. W. C. Cho, “Most common cancers in Asia-Pacific region: nasopharyngeal carcinoma,” in Cancer Report of Asian-Pacific Region 2010, pp. 284–289, Asian Pacific Organization for Cancer Prevention, 2010. View at Google Scholar
  3. S. Qu, Z.-G. Liang, and X.-D. Zhu, “Advances and challenges in intensity-modulated radiotherapy for nasopharyngeal carcinoma,” Asian Pacific Journal of Cancer Prevention, vol. 16, no. 5, pp. 1687–1692, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. A. D. King, A. C. Vlantis, T. W. C. Yuen et al., “Detection of nasopharyngeal carcinoma by MR imaging: Diagnostic accuracy of MRI compared with endoscopy and endoscopic biopsy based on long-term follow-up,” American Journal of Neuroradiology, vol. 36, no. 12, pp. 2380–2385, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Raab-Traub, “Nasopharyngeal carcinoma: An evolving role for the epstein–barr virus,” Current Topics in Microbiology and Immunology, vol. 390, pp. 339–363, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-F. Tang, Z.-H. Yu, T. Liu et al., “Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 18, pp. 7575–7581, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Jiang, N. Liu, X.-Z. Chen et al., “Genome-wide identification of a methylation gene panel as a prognostic biomarker in nasopharyngeal carcinoma,” Molecular Cancer Therapeutics, vol. 14, no. 12, pp. 2864–2873, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Schwarzenbach, D. S. B. Hoon, and K. Pantel, “Cell-free nucleic acids as biomarkers in cancer patients,” Nature Reviews Cancer, vol. 11, no. 6, pp. 426–437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Zhang, H. Zhao, Y. Gao, and W. Zhang, “Secretory miRNAs as novel cancer biomarkers,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1826, no. 1, pp. 32–43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Cortez, C. Bueso-Ramos, J. Ferdin, G. Lopez-Berestein, A. K. Sood, and G. A. Calin, “MicroRNAs in body fluids—the mix of hormones and biomarkers,” Nature Reviews Clinical Oncology, vol. 8, no. 8, pp. 467–477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Konishi, D. Ichikawa, S. Komatsu et al., “Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma,” British Journal of Cancer, vol. 106, no. 4, pp. 740–747, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Zanutto, S. Pizzamiglio, M. Ghilotti et al., “Circulating miR-378 in plasma: A reliable, haemolysis-independent biomarker for colorectal cancer,” British Journal of Cancer, vol. 110, no. 4, pp. 1001–1007, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Zeng, J. Xiang, M. Wu et al., “Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma,” PLoS ONE, vol. 7, no. 10, Article ID e46367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Liu, H.-N. Luo, W.-D. Tian et al., “Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma,” Cancer biology & therapy, vol. 14, no. 12, pp. 1133–1142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Liu, R.-X. Cui, Y. Sun et al., “A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma,” International Journal of Cancer, vol. 134, no. 6, pp. 1359–1368, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Zhang, J. Zong, S. Lin et al., “Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment,” International Journal of Cancer, vol. 136, no. 5, pp. E301–E312, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Lu, X. Xu, X. Liu et al., “Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis,” British Journal of Cancer, vol. 110, no. 2, pp. 392–398, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. D. G. Pfister, K.-K. Ang, D. M. Brizel, R. S. Weber, G. T. Wolf, F. Worden et al., “Head and neck cancers,” Journal of the National Comprehensive Cancer Network, vol. 9, pp. 596–650, 2011. View at Google Scholar · View at Scopus
  21. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Kosaka, H. Iguchi, and T. Ochiya, “Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis,” Cancer Science, vol. 101, no. 10, pp. 2087–2092, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Leidinger, A. Keller, C. Backes, H. Huwer, and E. Meese, “MicroRNA expression changes after lung cancer resection: A follow-up study,” RNA Biology, vol. 9, no. 6, pp. 900–910, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Zen and C.-Y. Zhang, “Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers,” Medicinal Research Reviews, vol. 32, no. 2, pp. 326–348, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Summerer, M. Niyazi, K. Unger et al., “Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients,” Journal of Radiation Oncology, vol. 8, no. 1, article 296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. C. Lee, J. T. Zhao, R. J. Clifton-Bligh et al., “MicroRNA-222 and MicroRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer,” Cancer, vol. 119, no. 24, pp. 4358–4365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Shivapurkar, L. M. Weiner, J. L. Marshall et al., “Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs,” PLoS ONE, vol. 9, no. 1, Article ID e84686, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. L. A. Selth, S. L. Townley, A. G. Bert et al., “Circulating microRNAs predict biochemical recurrence in prostate cancer patients,” British Journal of Cancer, vol. 109, no. 3, pp. 641–650, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Chabre, R. Libé, G. Assie et al., “Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients,” Endocrine-Related Cancer, vol. 20, no. 4, pp. 579–594, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. E. M. Kroh, R. K. Parkin, P. S. Mitchell, and M. Tewari, “Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR),” Methods, vol. 50, no. 4, pp. 298–301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. C. C. Pritchard, E. Kroh, B. Wood et al., “Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies,” Cancer Prevention Research, vol. 5, no. 3, pp. 492–497, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Hu, Z. Wang, B.-Y. Liao et al., “Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients,” International Journal of Cancer, vol. 135, no. 5, pp. 1187–1194, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Sromek, M. Glogowski, M. Chechlinska et al., “Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection,” Cellular Oncology, vol. 40, no. 5, pp. 529–536, 2017. View at Publisher · View at Google Scholar
  34. Y. Cui, Y. Xue, S. Dong, and P. Zhang, “Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma,” Journal of International Medical Research, vol. 45, no. 4, pp. 1310–1317, 2017. View at Publisher · View at Google Scholar
  35. B. Sun, X. Liu, Y. Gao, L. Li, and Z. Dong, “Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients,” British Journal of Biomedical Science, vol. 73, no. 4, pp. 152–157, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Medina-Villaamil, S. Martínez-Breijo, P. Portela-Pereira et al., “Circulating MicroRNAs in blood of patients with prostate cancer,” Actas Urológicas Españolas (English Edition), vol. 38, no. 10, pp. 633–639, 2014. View at Publisher · View at Google Scholar
  37. J. Lu, H. Luo, X. Liu et al., “miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma,” Carcinogenesis, vol. 35, no. 3, Article ID bgt354, pp. 554–563, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. X. H. Peng, H. R. Huang, J. Lu et al., “MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma,” Molecular Cancer, vol. 13, p. 186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Ding, Y. Pan, S. Liu, F. Jiang, and J. Jiao, “Elevation of MiR-9–3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV,” Cancer Biology & Therapy, vol. 18, no. 6, pp. 414–424, 2017. View at Publisher · View at Google Scholar
  40. H. Hu, G. Wang, and C. Li, “miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4,” OncoTargets and Therapy, vol. 10, pp. 2711–2720, 2017. View at Publisher · View at Google Scholar
  41. S. Xu, N. Zhao, L. Hui, M. Song, Z.-W. Miao, and X.-J. Jiang, “MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3,” Oncology Reports, vol. 35, no. 3, pp. 1385–1394, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. S.-S. Shin, S.-S. Park, B. Hwang et al., “MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways,” Oncology Reports, vol. 36, no. 4, pp. 2313–2320, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Balatti, L. Rizzotto, C. Miller et al., “TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 112, no. 7, pp. 2169–2174, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Liu, W. Chen, Z. Chen et al., “The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma,” Biomedicine & Pharmacotherapy, vol. 93, pp. 869–878, 2017. View at Publisher · View at Google Scholar
  45. X. Lyu, W. Fang, L. Cai et al., “TGFbetaR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness,” Molecular Cancer, vol. 13, no. 1, article 51, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Wu, X. Ye, S. Wang, Q. Li, Y. Lai, and Y. Yi, “MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2,” OncoTargets and Therapy, vol. 10, pp. 2815–2822, 2017. View at Publisher · View at Google Scholar
  47. F.-P. Zhao, X. Liu, Z.-M. Zhong et al., “Positivity of both plasma Epstein-Barr virus DNA and serum Epstein-Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma,” BBA Clinical, vol. 2, pp. 88–93, 2014. View at Publisher · View at Google Scholar · View at Scopus